About Vuno
Vuno is a company based in Seoul (South Korea) founded in 2014 by Kim Hyun-Jun. Vuno has raised $18.8 million across 3 funding rounds from investors including SBI Group, HB Investment and Smile Gate Investment. Vuno offers products and services including VUNO Med-Chest X-ray, VUNO Med-BoneAge, VUNO Med-Fundus AI, VUNO Med-LungCT AI, and VUNO Care-Hativ. Vuno operates in a competitive market with competitors including AIdoc, Viz.ai, Perspectum, Qure.ai and IXICO, among others.
- Headquarter Seoul, South Korea
- Founders Kim Hyun-Jun
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Vuno Inc.
-
Annual Revenue
$24.12 M (USD)34.71as on Dec 31, 2025
-
Net Profit
-$4 M (USD)55.59as on Dec 31, 2025
-
EBITDA
-$7.4 M (USD)23.41as on Dec 31, 2024
-
Total Equity Funding
$18.8 M (USD)
in 3 rounds
-
Latest Funding Round
$6.8 M (USD), Series B
Dec 02, 2025
-
Investors
SBI Group
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Vuno
Vuno is a publicly listed company on the KRX with ticker symbol 338220 in South Korea, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Vuno
Vuno offers a comprehensive portfolio of products and services, including VUNO Med-Chest X-ray, VUNO Med-BoneAge, VUNO Med-Fundus AI, VUNO Med-LungCT AI, and VUNO Care-Hativ.
AI tool for detecting abnormalities in chest X-rays.
AI solution for assessing bone age from images.
AI for identifying eye conditions in fundus images.
AI for detecting lung nodules in CT scans.
AI platform for chronic disease management services.
People of Vuno
Unlock access to complete
Funding Insights of Vuno
Vuno has successfully raised a total of $18.8M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $6.8 million completed in December 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Vuno
Vuno has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include SBI Group, HB Investment and Smile Gate Investment.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investment firm focused on buyouts
|
Locked | Locked | Locked | |
|
Venture capital firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
FuturePlay is engaged in startup investment and acceleration.
|
Locked | Locked | Locked |
Investor details for Vuno
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Vuno
Investment portfolio details for Vuno
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Vuno
Detailed financials for Vuno
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vuno Comparisons
Peer comparison for Vuno
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Vuno
Vuno operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AIdoc, Viz.ai, Perspectum, Qure.ai and IXICO, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-based single-screen system is provided to streamline medical imaging.
|
|
| Locked | Locked | Locked |
AI and cloud-powered software for stroke care coordination is developed.
|
|
| Locked | Locked | Locked |
Precision medicine software for liver disease diagnosis is offered.
|
|
| Locked | Locked | Locked |
AI-powered solutions for medical imaging diagnostics
|
|
| Locked | Locked | Locked |
AI-based medical image management and analysis solutions for healthcare organizations
|
|
| Locked | Locked | Locked |
Provider of AI and SaaS-based medical image based decision support tools
|
Detailed competitors of Vuno
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vuno
Complete news archive for Vuno
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vuno
Vuno was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Vuno is headquartered in Seoul, South Korea.
Vuno is a funded company, having raised a total of $18.8M across 3 funding rounds to date.
Annual revenue of Vuno is $24.12M as on Dec 31, 2025.
Developer of AI based medical image analysis software for healthcare providers. The companys solutions analyzes a wide range of medical data that can be combined with artificial intelligence. The companys products include Med-BoneAge, Med-DeepBrain, Med-Chest X-ray, Med-Fundus AI, Med-LungCT AI and more.
Vuno's top competitors include Perspectum, Qure.ai and AIdoc.
Vuno offers VUNO Med-Chest X-ray, VUNO Med-BoneAge, VUNO Med-Fundus AI, VUNO Med-LungCT AI, and VUNO Care-Hativ.
Yes, Vuno is publicly traded on KRX under the ticker symbol 338220.
Vuno has 5 investors. Key investors include SBI Group, HB Investment, Smile Gate Investment, FuturePlay, and BonAngels Venture Partners.
The ticker symbol of Vuno is 338220 on KRX.